Jiangyong Miao

Also affiliated with Second Hospital of Hebei Medical University, Hebei University of Chinese Medicine

MedicineBiochemistry, Genetics and Molecular BiologyNeuroscience

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “FOXC2 Promotes Vasculogenic Mimicry in Ovarian Cancer”.

FOXC2 Promotes Vasculogenic Mimicry in Ovarian Cancer

Cancers(2022)10.3390/cancers14194851

N/A

0DataRank · unranked

31 citations

Jiangyong Miao, Maricel Gozo, Jingni Wu, Ann E. Walts, Beth Y. Karlan +2 more

Data from Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene

(2023)10.1158/0008-5472.c.6500892

N/A

0DataRank · unranked

0 citations

Runsheng Wang, Jiangyong Miao, Esther Oliva, Xiaoyun Shen, Thomas M. Wheeler +4 more

Data from Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene

(2023)10.1158/0008-5472.c.6500892.v1

N/A

0DataRank · unranked

0 citations

Runsheng Wang, Jiangyong Miao, Esther Oliva, Xiaoyun Shen, Thomas M. Wheeler +4 more

Data from MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance

(2023)10.1158/1078-0432.c.6517996

N/A

0DataRank · unranked

0 citations

Jiangyong Miao, Daniel P. Cahill, A. John Iafrate, Ken Aldape, Catherine L. Nutt +2 more

Data from MSH6 Mutations Arise in Glioblastomas during Temozolomide Therapy and Mediate Temozolomide Resistance

(2023)10.1158/1078-0432.c.6517996.v1

N/A

0DataRank · unranked

0 citations

Jiangyong Miao, Daniel P. Cahill, A. John Iafrate, Ken Aldape, Catherine L. Nutt +2 more